107 related articles for article (PubMed ID: 20045449)
1. Enhanced vulnerability of PARK6 patient skin fibroblasts to apoptosis induced by proteasomal stress.
Klinkenberg M; Thurow N; Gispert S; Ricciardi F; Eich F; Prehn JH; Auburger G; Kögel D
Neuroscience; 2010 Mar; 166(2):422-34. PubMed ID: 20045449
[TBL] [Abstract][Full Text] [Related]
2. PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c.
Wang HL; Chou AH; Yeh TH; Li AH; Chen YL; Kuo YL; Tsai SR; Yu ST
Neurobiol Dis; 2007 Nov; 28(2):216-26. PubMed ID: 17707122
[TBL] [Abstract][Full Text] [Related]
3. Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress.
Muqit MM; Abou-Sleiman PM; Saurin AT; Harvey K; Gandhi S; Deas E; Eaton S; Payne Smith MD; Venner K; Matilla A; Healy DG; Gilks WP; Lees AJ; Holton J; Revesz T; Parker PJ; Harvey RJ; Wood NW; Latchman DS
J Neurochem; 2006 Jul; 98(1):156-69. PubMed ID: 16805805
[TBL] [Abstract][Full Text] [Related]
4. Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients.
Rakovic A; Grünewald A; Seibler P; Ramirez A; Kock N; Orolicki S; Lohmann K; Klein C
Hum Mol Genet; 2010 Aug; 19(16):3124-37. PubMed ID: 20508036
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.
Hoepken HH; Gispert S; Morales B; Wingerter O; Del Turco D; Mülsch A; Nussbaum RL; Müller K; Dröse S; Brandt U; Deller T; Wirth B; Kudin AP; Kunz WS; Auburger G
Neurobiol Dis; 2007 Feb; 25(2):401-11. PubMed ID: 17141510
[TBL] [Abstract][Full Text] [Related]
6. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.
Pridgeon JW; Olzmann JA; Chin LS; Li L
PLoS Biol; 2007 Jul; 5(7):e172. PubMed ID: 17579517
[TBL] [Abstract][Full Text] [Related]
7. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations.
Petit A; Kawarai T; Paitel E; Sanjo N; Maj M; Scheid M; Chen F; Gu Y; Hasegawa H; Salehi-Rad S; Wang L; Rogaeva E; Fraser P; Robinson B; St George-Hyslop P; Tandon A
J Biol Chem; 2005 Oct; 280(40):34025-32. PubMed ID: 16079129
[TBL] [Abstract][Full Text] [Related]
8. PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons.
Wang HL; Chou AH; Wu AS; Chen SY; Weng YH; Kao YC; Yeh TH; Chu PJ; Lu CS
Biochim Biophys Acta; 2011 Jun; 1812(6):674-84. PubMed ID: 21421046
[TBL] [Abstract][Full Text] [Related]
9. Parkinson patient fibroblasts show increased alpha-synuclein expression.
Hoepken HH; Gispert S; Azizov M; Klinkenberg M; Ricciardi F; Kurz A; Morales-Gordo B; Bonin M; Riess O; Gasser T; Kögel D; Steinmetz H; Auburger G
Exp Neurol; 2008 Aug; 212(2):307-13. PubMed ID: 18511044
[TBL] [Abstract][Full Text] [Related]
10. The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells.
Giuliano M; Lauricella M; Calvaruso G; Carabillò M; Emanuele S; Vento R; Tesoriere G
Cancer Res; 1999 Nov; 59(21):5586-95. PubMed ID: 10554039
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1.
Takatori S; Ito G; Iwatsubo T
Neurosci Lett; 2008 Jan; 430(1):13-7. PubMed ID: 18031932
[TBL] [Abstract][Full Text] [Related]
12. L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner.
Moriwaki Y; Kim YJ; Ido Y; Misawa H; Kawashima K; Endo S; Takahashi R
Neurosci Res; 2008 May; 61(1):43-8. PubMed ID: 18359116
[TBL] [Abstract][Full Text] [Related]
13. The ubiquitin E3 ligase CHIP promotes proteasomal degradation of the serine/threonine protein kinase PINK1 during staurosporine-induced cell death.
Yoo L; Chung KC
J Biol Chem; 2018 Jan; 293(4):1286-1297. PubMed ID: 29242192
[TBL] [Abstract][Full Text] [Related]
14. Cytosolic PINK1 orchestrates protein translation during proteasomal stress by phosphorylating the translation elongation factor eEF1A1.
Qin S; Ye L; Zheng Y; Gao J
FEBS Lett; 2021 Feb; 595(4):507-520. PubMed ID: 33354788
[TBL] [Abstract][Full Text] [Related]
15. Application of proteasomal inhibitors to mouse sympathetic neurons activates the intrinsic apoptotic pathway.
Lang-Rollin I; Vekrellis K; Wang Q; Rideout HJ; Stefanis L
J Neurochem; 2004 Sep; 90(6):1511-20. PubMed ID: 15341534
[TBL] [Abstract][Full Text] [Related]
16. Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1.
Weihofen A; Ostaszewski B; Minami Y; Selkoe DJ
Hum Mol Genet; 2008 Feb; 17(4):602-16. PubMed ID: 18003639
[TBL] [Abstract][Full Text] [Related]
17. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
[TBL] [Abstract][Full Text] [Related]
18. PINK1 phosphorylates transglutaminase 2 and blocks its proteasomal degradation.
Min B; Kwon YC; Choe KM; Chung KC
J Neurosci Res; 2015 May; 93(5):722-35. PubMed ID: 25557247
[TBL] [Abstract][Full Text] [Related]
19. Caspase-8 dependent osteosarcoma cell apoptosis induced by proteasome inhibitor MG132.
Yan XB; Yang DS; Gao X; Feng J; Shi ZL; Ye Z
Cell Biol Int; 2007 Oct; 31(10):1136-43. PubMed ID: 17493842
[TBL] [Abstract][Full Text] [Related]
20. Detailed analysis of mitochondrial respiratory chain defects caused by loss of PINK1.
Amo T; Saiki S; Sawayama T; Sato S; Hattori N
Neurosci Lett; 2014 Sep; 580():37-40. PubMed ID: 25092611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
